Latest Videos
Video
The Undoing: The Demise of the T Cell in GBM and Intracranial Tumors
Dr. Peter Fecci from Duke University explores T-cell dysfunction in glioblastoma.
Video
Ann Lacasce, MD, MMSc discusses treatment in early stage high-risk cHL patients
Ann Lacasce MD, MMSc, of Dana-Farber Cancer Institute presented findings at #ASH24 suggesting treatment with brentuximab vedotin and nivolumab can reduce toxicities and may decrease the need for radiation in early stage high-risk cHL patients.
Video
Jacqueline Garcia, MD on oral maintenance therapy in AML/MDS patients
Jacqueline Garcia, MD, of Dana-Farber Cancer Institute presented at #ASH24 data suggesting oral maintenance therapy with venetoclax and decitabine/cedazuridine after HCT is safe, feasible, and may reduce relapse rates in high-risk AML/MDS patients.
Video
Katie Maurer, MD, PhD discusses HSCT treatment
Katie Maurer, MD, PhD, from Dana-Farber Cancer Institute, shared #ASH24 findings suggesting that diverse bone marrow cell composition may predict treatment response in the content of AML patients undergoing HSCT.
Video
Jennifer Brown, MD, PhD reviews Phase 2 Amplify trial
Dana-Farber Cancer Institute's Jennifer Brown, MD, PhD, shared results at #ASH24 from the Phase 3 AMPLIFY trial: novel oral regimens show promise for CLL with durable, deep responses.
Video
Colleen Kelly, MD discusses findings on RISE
At #ASH24, researcher, Colleen Kelly MD, presented findings on RISE, a Dana-Farber led program aiding low-income families of kids with cancer. Results show promise.
Video
Shai Shimony, MD, MPH reviews Phase 3 acute myeloid leukemia trial
Findings from a Phase 3 acute myeloid leukemia trial presented at #ASH24 show CPX-351 improves survival for AML-MR patients. Lead authors Shai Shimony, MD, MPH, and H. Moses Murdoch, MD, of Dana-Farber Cancer Institute, explain more in this video.
Video
Daniel DeAngelo, MD, PhD on a novel systemic mastocytosis (SM) drug
Daniel DeAngelo, MD, PhD, of Dana-Farber Cancer Institute, presented findings at #ASH24 on two abstracts regarding a novel systemic mastocytosis (SM) drug with high response rates & a tool that identifies SM subtypes with 90% accuracy.
Latest Documents
Document
Impact of Virtual Preoperative Evaluations on Complications of MIGS
A recent study, published in The Journal of Minimally Invasive Gynecology, found that patients scheduled for minimally invasive gynecologic surgery (MIGS) who had only virtual visits with their surgeon until the day of surgery ...
Document
Case Spotlight: Advanced Polyp Resection Using DiLumen® in the Distal Sigmoid Colon
This new clinical case report showcases an innovative use of the DiLumen® Endoluminal Interventional Platform (EIP) by Dr. Sandro Sferrazza at Santa Chiara Hospital, Italy.
Latest Articles
News
Proof that AI Tools Are Enhancing Breast Cancer Detection
The evidence is out. Artificial intelligence (AI)-assisted breast cancer screening is helping find small cancers earlier and may ensure that some breast cancers are not overestimated.
News
Advanced Heart Valve Procedures Expand Treatments for Patients With Limited Options
Heart specialists at the Washington University and Barnes-Jewish Heart & Vascular Center in St. Louis, Mo., are pioneering advances that enhance the quality of life for patients who have historically suffered debilitating symptoms with ...
News
Epilepsy affects approximately 3 million Americans, with a lifetime risk of 1 in 26.
News
Mount Sinai Study Finds Wearable Devices Can Detect and Predict Inflammatory Bowel Disease Flare-Ups
Data collected by wearable technology can identify disease flare-ups up to seven weeks in advance.
Latest Courses
Course
Hyperthyroidism and Thyroid Eye Disease Updates
In this CME, Esra Karslioglu French, MD, and S. Tonya Stefko, MD, discuss how to implement Thyroid Eye Disease outcomes by utilizing correct diagnosis and treatment strategies, recognizing the treatment indications and side effects of ...
Course
In this CME, Manish Gupta, MD, discusses factors in kidney allocation and describes the benefits of living kidney donation.
Course
2025 Cedars-Sinai International Endoscopy Symposium
Thursday, January 30, 2025, 7:30 AM - Saturday, February 1, 2025, 5:45 PM PST, Cedars-Sinai Harvey Morse Conference Center, Los Angeles, CA
Course
The 16th Annual Symposium on Neurovascular Disease
Saturday, January 25, 2025, 7:30 AM - 5:10 PM PST, Other, Santa Monica, CA
